Impact investor

4BIO Capital

78 Pall Mall London SW1Y 5ES United Kingdom
Investor type PE / VC
Founded 2014
AUM -
Location Russia

Profile

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space.

Industry focus

Life Sciences MedTech Biotechnology

Investment preferences

Investment Ticket

$1-5 m

Investment Horizon

3-5 years

Investment Stage

Seed

Round A and B

Exit Strategy

IPO

Sale to strategic investor

Region focus

Europe North America Asia

Contacts

Name
Title
E-mail
Social

Name

Name

Title

Title

E-mail

email@email.com

Social

Name

Name

Title

Title

E-mail

email@email.com

Social

Name

Name

Title

Title

E-mail

email@email.com

Social

If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!